Publication details

1. Jagmag T, Tirant M, Lotti  T.  Link between cutaneous infection, stress and depression.  J Biol Regul Homeost Agents. 2017;31(4):1037-1041. Click here

2. Sreevallabhan S, Mohanan R, Sukumaran S, Sobha A P, Jose S P, Sukumarpillai A, Jagmag T, Tilwani J. Ameliorating effect of glutathione- enriched herbal formulation (glothione) on alloxan-induced experimental diabetic model by modulating oxidative stress and pathogenesis. J Food Biochem. 2020; 00: e13153. Click here

3. Ratheesh M, Sheethal S, Svenia P. Jose, Sony Rajan, Sulumol Thomas, Tariq Jagmag & Jayesh Tilwani(2020) Biochemical and immunological aspects of COVID-19 infection and therapeutical intervention of oral low dose cytokine therapy: a systematic review. Immunopharmacology and Immunotoxicology,  DOI: 1080/08923973.2020.1842444. Click here 

4. Sreevallabhan S, Mohanan R, Jose SP, Sukumaran S, Jagmag T, Tilwani J, Kulkarni A.    Hepatoprotective effect of essential phospholipids enriched with virgin coconut oil (Phoscoliv) on paracetamol induced liver toxicity. J Food Biochem. 2021;00:e13606. Click here

5. Ratheesh, M., Sunil, S., Sheethal, S. Jose S, Sandya S, Ghosh OSN, Rajan S, Jagmag T, Tilwani J. Anti-inflammatory and antiCOVID-19 effect of a novel polyherbal formulation (Imusil) via modulating oxidative stress, inflammatory mediators and cytokine storm. Inflammopharmacol 30, 173–184 (2022). Click here

6. Abhyankar M, Kadam D, Reddy P, et al. (March 07, 2023) The Efficacy and Safety of Imusil® Tablets in the Treatment of Adult Patients With Mild COVID-19: A Prospective, Randomized, Multicenter, Open-Label Study. Cureus 15(3): e35881. doi:10.7759/cureus.35881 Click here

7. Ratheesh et al Immunomodulatory Effect of a Polyherbal Formulation (Imusil) on Cyclophosphamide Induced Experimental Animal Model. APJCP. 2023; 24(11)3729-37 click here

Conference presentations

 

1.Invited speaker on the topic of “Treating resistant chronic infections with calium EDTA: case presentation” at International Nutritional and Environment medicine conference – Jun 2017, Cochin, India.

2. Poster presentation at 2019 FOCIS Asian Advanced Course in Basic & Clinical Immunology

1) Effect of low dose interferon beta and essential phospholipids in patients with atherosclerosis  and mild hypertension
2) Low dose interleukin 10 and anti interleukin 1 in treatment of endometrial hyperplasia and  rheumatoid arthritis

3. Invited speaker on the topic of “Low dose cytokines, homeopathic and phytomedicine in infections” at International conference on Homeopathy and Phytomedicine – Jan 2020, St Thomas college, Pala, India

4. Invited speaker on the topic “Cytokine milieu in COVID-19 and its management” at Malaysian Association of Advancement of Functional and          Interdisciplinary Medicine (MAAFIM) virtual conference : COVID-19 summit held from 10-11 Apr 2021. Watch in here.

5. Poster presentation on “Cytokine Milieu in COVID-19 and therapeutical interventions of oral low dose cytokine therapy” at 21st annual meeting of the Federation of Clinical Immunology Societies (FOCIS 2021 vitual conference from 8-11 Jun 2021).

6. Invited speaker on the topic of “Long COVID” by Healing our Earth platform on 12 Dec 2021.

7. Invited speaker on the topic of “Long COVID” by World Council for Health platform on 22 Dec 2021. Watch it here.

8. Invited speaker on 7th Annual Nutrition Summit, Mumbai, India on 28-29 Apr 2022 on topic “Anti-inflammatory, antiviral, antioxidant properties of Imusil which enables it to treat Covid, Long Covid and reduces belly fat too”.

9. Invited for panel discussion on 7th Annual Nutrition Summit, Mumbai, India on 28-29 Apr 2022 on topic “Obesity and weight management: Nutraceuticals in endocrine and metabolic disorders”.

10. Invited speaker at International Conference on Clinical Nutrition & Dietary Lifestyle 20-21 May 2022 at Bangalore, India on topic “Anti-inflammatory and anti covid effects of a novel polyherbal formulation (imusil) via modulating oxidative stress, inflammatory mediators and cytokine storms”.

11. Speaker at the 8th International Conference on Public Health – “Impact of Covid-19 Pandemic on Public Health, Economy and
the Government Sector: Tackling the Present and Shaping the Future” on topic “Novel polyherbal formulation (Imusil) as an anti-inflammatory and antiviral against COVID, 28-29 July 2022.

12. Invited speaker for WCFTN 2022 conference on 18 Aug 2022 in Paris, France on “Anti-inflammatory and anti-covid effects of a novel polyherbal formulation (imusil) via modulating oxidative stress, inflammatory mediators and cytokine storms”.

13. Invited speaker at Malaysian Association of Advancement of Functional and Interdisciplinary Medicine (MAAFIM) conference 3-6 Nov 2022 on topics :

• Public forum on topic “Reset your metabolism and your health” 
• Immune-biotechnology : New frontiers in Immunology
• Understanding virology : Viral escape and managing acute viral infections
• Autoimmune and gut health

14. Invited speaker at ICTAM 2023 conference on Taditional and alternative medicine in Kochi 19-20 Jan 2023 on topic “A single natural topical product which treats acne, pigmentation and signs of aging.”

15. Elite Doctor’s conference in Malaysia 11-12 Feb 2023 with Energivity Life.

16. Invited speaker at 3RD INTERNATIONAL “ THE BETTER WAY MAAFIM CONFERENCE” 14TH – 17TH SEP 2023- Malaysia

17. Elite Doctor’s conference 2024 – Hogwarts Medical in Malaysia 27-28 Jan 2024 with Energivity Life

18. Invited speaker at CanSurvive Centre Malaysia webinar, 23 Mar 2024 on topic “Effect of novel food Imusil on cancer and chemotherapy induced immunosuppression”

19. Speaker at upcoming conference in Jakarta, June 2024